The Vaginal Probiotic Built on Real Science, Flora Sync LF5

Walk into any pharmacy or scroll any wellness feed and you’ll find no shortage of women’s health probiotic products. Gummies, oral capsules, vaginal suppositories with pastel packaging and language borrowed from the gut health aisle. They promise balance, freshness, confidence. What most of them don’t have is a clinical study to back any of it up, or a strain that was ever actually isolated from the vaginal microbiome to begin with.

Daré Bioscience’s Flora Sync LF5 is different in a way that sounds simple but is, in practice, quite rare. Isolated directly from the vaginal microbiome of healthy women. Studied in a randomized controlled trial published in a peer-reviewed journal. Delivered directly to the vaginal environment. Find another women’s health probiotic that does all three. We’ll wait.

The key ingredient is Limosilactobacillus fermentum LF5, a specific probiotic strain originally isolated from the vaginal microbiome of healthy women with no reported history of yeast infections. That distinction matters. Most oral probiotics sold for “women’s health” are gut strains repurposed on the assumption that they’ll somehow navigate the digestive system and arrive intact in the vagina – and take a minute to think through what needs to happen to make that true. Hint: your digestive tract has one entrance and one exit.

“Flora Sync LF5 was developed specifically for vaginal health, not gut health. By delivering a vagina-specific probiotic strain directly to the vaginal environment, Flora Sync LF5 represents a targeted approach to supporting vaginal wellness.”

Sabrina Martucci Johnson President and Chief Executive Officer, Daré Bioscience

In a single-blind, randomized controlled clinical trial of 100 women, published in Frontiers in Microbiology in 2024, 96% of women achieved vaginal microbiome balance within three days. At two weeks, 90% maintained that balance. These are not testimonials or self-reported results.

The study design matters here too. A randomized controlled trial is the gold standard in clinical research — and it is not the standard most supplement brands bother with at all. The fact that a consumer vaginal probiotic has this kind of evidence behind it is genuinely unusual. Most products in this space rely on marketing language rather than clinical data. Flora Sync LF5 is backed by a published, peer-reviewed trial — because the researchers behind it decided women in the consumer market deserved the same scientific rigor applied to any serious health product.

The vaginal microbiome is a surprisingly delicate ecosystem, dominated under healthy conditions by beneficial bacteria (primarily Lactobacillus species) that maintain a protective, slightly acidic environment. Everyday factors, including stress, hormonal changes, intimacy, antibiotics, and routine changes like travel or new products, can disrupt this balance, leading to vaginal odor, vaginal discomfort, and reduced confidence. Flora Sync LF5 is designed to help support the natural balance of the vaginal microbiome.

The women’s wellness market has a credibility problem. Decades of vague claims, proprietary blends, and marketing dressed up as science have trained consumers, rightly, to be skeptical. At the same time, vaginal health has been chronically underserved: most wellness brands have filled the gap with products that sound good rather than ones that work.

Flora Sync LF5 sits at an unusual intersection: a strain born from real research, manufactured under current Good Manufacturing Practices (cGMP) standards, brought to market by Daré Bioscience, a women’s health biotech whose entire mission is accelerating innovation for women and whose instinct is to ask for evidence before making a claim. Flora Sync LF5 is almost certainly the most rigorously sourced vaginal probiotic most women will ever encounter, because the people behind it didn’t know how to do it any other way.

That’s not a marketing angle. That’s just what happens when serious scientists choose a serious partner, and both of them decide women’s everyday health deserves better than what’s currently on the shelf.